期刊
MOLECULAR PSYCHIATRY
卷 27, 期 2, 页码 819-830出版社
SPRINGERNATURE
DOI: 10.1038/s41380-021-01182-2
关键词
-
资金
- CMU fellowship
- TWF Changing Minds Programme
- Welcome [100202/Z/12/Z]
- Hodge Foundation
- MRC [MR/NO22572/1, MR/L011166/1, MR/L010305/1, G0800509]
- Health and Care Research Wales
- MRC [MR/L011166/1, G0800509] Funding Source: UKRI
- Wellcome Trust [100202/Z/12/Z] Funding Source: Wellcome Trust
Copy Number Variation (CNV) at the 1q21.1 locus is associated with a range of neurodevelopmental and psychiatric disorders in humans, with deletion or duplication of this locus leading to reciprocal phenotypes in neuronal development. These differences are also conserved in a mouse model of 1q21.1 deletion, indicating potential for drug interventions through targeting calcium channels in neurons with 1q21.1 deletion or duplication.
Copy Number Variation (CNV) at the 1q21.1 locus is associated with a range of neurodevelopmental and psychiatric disorders in humans, including abnormalities in head size and motor deficits. Yet, the functional consequences of these CNVs (both deletion and duplication) on neuronal development remain unknown. To determine the impact of CNV at the 1q21.1 locus on neuronal development, we generated induced pluripotent stem cells from individuals harbouring 1q21.1 deletion or duplication and differentiated them into functional cortical neurons. We show that neurons with 1q21.1 deletion or duplication display reciprocal phenotype with respect to proliferation, differentiation potential, neuronal maturation, synaptic density and functional activity. Deletion of the 1q21.1 locus was also associated with an increased expression of lower cortical layer markers. This difference was conserved in the mouse model of 1q21.1 deletion, which displayed altered corticogenesis. Importantly, we show that neurons with 1q21.1 deletion and duplication are associated with differential expression of calcium channels and demonstrate that physiological deficits in neurons with 1q21.1 deletion or duplication can be pharmacologically modulated by targeting Ca2+ channel activity. These findings provide biological insight into the neuropathological mechanism underlying 1q21.1 associated brain disorder and indicate a potential target for therapeutic interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据